Descriptors of Participants Eligible for Analysis of Heartburn/Regurgitation in Relation to Esophageal Adenocarcinoma and Esophagogastric Junction Adenocarcinoma.

The median and interquartile range of each variable are provided, unless the variable is stated to be a percentage in which case the percentage and 95 percent confidence interval are provided. *This includes PPIs, H2RAs, antacids, and non-specific questions about anti-reflux medications/remedies. Abbreviations: EA, esophageal adenocarcinoma; EGJA, esophagogastric junction adenocarcinoma; FINBAR, Factors Influencing the Barrett’s Adenocarcinoma Relationship (FINBAR) Study. 1Among those exposed.